戻る Agenda
ST00: Current Status of Clinical Development for Depression. -Issues, Lesson Learns, Solutions-
Session Chair(s)
Marika Uchida
Undergraduate
Meiji Pharmaceutical University, School of Pharmacy, Japan
Moeka Yamanoi
Undergraduate
Meiji Pharmaceutical University, School of Pharmacy, Japan
Yuni Shimbori
School of Pharmacy
Nihon University, Japan
Speaker(s)
Tetsuo Nakabayashi, MD, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Office of Medical Informatics and Epidemiology
Motoki Arakawa, PhD
Nihon University , Japan
Junior Associate Professor, School of Pharmacy
Katsuhiko Ichimaru
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Review Director, Office of New Drug IV
Hideki Maeda, PhD
Meiji Pharmaceutical University, Japan
Professor, Department of Regulatory Science
Jun Yamakami, PhD
Sanofi K.K., Japan
Senior Manager, R&D Regulatory 1, Regulatory Affairs
Saki Watanabe
Pfizer R&D Japan G.K., Japan
Monitoring Group
Ryohei Sato, MS
Otsuka Pharmaceutical Co., Ltd., Japan
Department of Clinical Research and Development
Minami Mori
IQVIA Services Japan K.K., Japan
CRA, Clinical Operations